Solid Biosciences Inc. (SLDB) Social Stream
SOLID BIOSCIENCES INC (SLDB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SLDB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 6 | $17 | $5.5 | $10.3 | $6.25 | 64.8% |
| 2022-03-14 | 5 | $17 | $5.5 | $10.3 | $6.25 | 64.8% |
| 2022-03-15 | 4 | $17 | $5 | $10.2 | $6.25 | 63.2% |
| 2022-04-28 | 5 | $17 | $5 | $9.4 | $6.25 | 50.4% |
| 2022-05-18 | 4 | $12 | $2 | $6.5 | $6.25 | 4% |
| 2022-08-11 | 5 | $12 | $2 | $6.5 | $6.25 | 4% |
| 2022-08-15 | 5 | $12 | $2 | $6.25 | $6.25 | 0% |
| 2022-10-03 | 5 | $12 | $1 | $6 | $6.25 | -4% |
| 2022-10-18 | 5 | $89.955 | $14.992 | $48.725 | $6.25 | 679.6% |
| 2022-11-11 | 6 | $89.955 | $6 | $37.383 | $6.25 | 498.13% |
| 2023-01-13 | 6 | $89.955 | $6 | $32.152 | $6.25 | 414.43% |
| 2023-05-12 | 6 | $89.955 | $6 | $23.591 | $6.25 | 277.46% |
The Trend in the Analyst Price Target
Over the past 22 months, SLDB's average price target has gone up $13.92.
SLDB reports an average of 1,100.68% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-12 | 5 | 12.000 | 2.000 | 6.250 | 0.80 | 681.25% |
| 2022-10-18 | 5 | 89.955 | 14.992 | 48.725 | 0.47 | 10267.02% |
| 2022-10-18 | 5 | 6.000 | 1.000 | 3.250 | 7.05 | -53.9% |
| 2023-01-13 | 6 | 89.955 | 6.000 | 23.591 | 6.75 | 249.5% |
| 2023-05-12 | 6 | 89.955 | 6.000 | 23.591 | 6.32 | 273.28% |
SLDB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 0 | 3 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
SLDB's average broker recommendation rating improved by 0.5 over the prior 14 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SLDB as an investment opportunity.
- SOLID BIOSCIENCES INC's variance in analysts' estimates is lower than -1404.52% of all US stocks.
- SLDB has a higher average analyst price target than 258.38% of all US stocks.
- In terms of how SOLID BIOSCIENCES INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 564.63% of that group.
- SOLID BIOSCIENCES INC's number of analysts covering the stock is greater than 479.59% of Healthcare stocks.
In the Pharmaceutical Products industry, XFOR, APTO, and OTLK are the three stocks most similar to SOLID BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is SLDB a Buy, Hold or Sell? See the POWR Ratings now!